Divalproex Sodium Extended-Release

TYA Pharmaceuticals🇺🇸 United States

FDA Page

Effective Date: Aug 20, 2014
Approval ID: 49a585a8-327a-44b2-b45b-7a0959724dc6
Products: 2 registered
Version: 4

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use divalproex sodium extended-release tablets safely and effectively. See full prescribing information for divalproex sodium extended-release tablets. Divalproex sodium extended-release tablets for oral use Initial U.S. Approval: 2000

Quick Stats

Total Products2

Labelers2

Label Sections21

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.